Policy Matters

The AACR and the FDA presented joint recommendations that include broadening clinical trial eligibility and engaging the community in clinical trial recruitment.

by Kenneth C. Anderson, MD; Lola A. Fashoyin-Aje, MD, MPH; Nicole Gormley, MD; and Paul G. Kluetz, MD

Research describes how communication gaps can shift extra burden to parents who are members of ethnic and racial minority groups.

by Marci A. Landsmann

At a symposium held during a virtual meeting of cancer researchers, panelists discussed the disproportionate impact COVID-19 has had on Black and Latino Americans, as well as members of other minority groups.

by Kevin McLaughlin

NCI Director Norman E. “Ned” Sharpless addresses disparities and maps out plans for the future amid “profound upheaval.”

by Kevin McLaughlin

POLICY MATTERS

Cancer outcomes are changing for the better, but advances are not affecting all patients equally.

by Brian Rivers, PhD

Genetic testing for mutations in the BRCA1 and BRCA2 genes creates opportunities for cancer risk reduction. But 25 years after the mutations were discovered, some who could benefit from testing are still left out.

by Sue Rochman

FORWARD LOOK

Programs aim to increase awareness of benefits.

by Sue Rochman

In a study of women with breast cancer in North Carolina, those who lived in rural areas or were black were more likely than urban white women to report negative changes in their employment.

by Pamela Rafalow Grossman

A coalition of wives of African leaders, originally dedicated to addressing HIV/AIDS, is now also taking on the growing problem of cancer.

by Bradley D. Miller, PhD

People with HIV who develop certain cancers are more likely to die from them than patients without HIV—even if they receive similar treatment.

by Jon Kelvey